Edinburgh Research Explorer

Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis

Research output: Contribution to journalArticle

Standard

Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis. / McDonald, Scott A; Pollock, Kevin G J; Barclay, Stephen T.; Goldberg, David J; Bathgate, Andrew J; Bramley, Peter; Dillon, John; Fraser, Andrew; Innes, Hamish; Kennedy, Nicholas; Morris, Judith; Went, April; Hayes, Peter; Hutchison, Sharon.

In: Journal of Viral Hepatitis, 10.2019.

Research output: Contribution to journalArticle

Harvard

McDonald, SA, Pollock, KGJ, Barclay, ST, Goldberg, DJ, Bathgate, AJ, Bramley, P, Dillon, J, Fraser, A, Innes, H, Kennedy, N, Morris, J, Went, A, Hayes, P & Hutchison, S 2019, 'Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis', Journal of Viral Hepatitis.

APA

McDonald, S. A., Pollock, K. G. J., Barclay, S. T., Goldberg, D. J., Bathgate, A. J., Bramley, P., ... Hutchison, S. (2019). Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis. Journal of Viral Hepatitis.

Vancouver

McDonald SA, Pollock KGJ, Barclay ST, Goldberg DJ, Bathgate AJ, Bramley P et al. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis. Journal of Viral Hepatitis. 2019 Oct.

Author

McDonald, Scott A ; Pollock, Kevin G J ; Barclay, Stephen T. ; Goldberg, David J ; Bathgate, Andrew J ; Bramley, Peter ; Dillon, John ; Fraser, Andrew ; Innes, Hamish ; Kennedy, Nicholas ; Morris, Judith ; Went, April ; Hayes, Peter ; Hutchison, Sharon. / Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis. In: Journal of Viral Hepatitis. 2019.